Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study have?
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study has 200 citations in the OpenAlex counts ScholarIQ stores.
When was Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study published?
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study has 2015 year in the ScholarIQ index.
What is the open-access status of Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study?
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study has bronze oa status in the ScholarIQ index.
What is the DOI of Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study?
The DOI for Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study is on the source record.
What is the PMID of Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study?
The PMID for Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study is on the source record.
What is the OpenAlex record for Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study?
The OpenAlex for Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study is on the source record.